Taurine suppresses platelet-derived growth factor (PDGF) BB-induced PDGF-β receptor phosphorylation by protein tyrosine phosphatase-mediated dephosphorylation in vascular smooth muscle cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1745, Issue 3, 2005, Pages 350-360

  Yoshimura, Hitoshi ^a   Nariai, Yuko ^a   Terashima, Masaharu ^a   Mitani, Toshifumi ^a   Tanigawa, Yoshinori ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Platelet derived growth factor; Platelet derived growth factor receptor; Protein tyrosine phosphatase; Taurine; Vascular smooth muscle cell

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; RAS PROTEIN; TAURINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ATHEROSCLEROSIS; BLOTTING, WESTERN; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED WKY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TAURINE;

EID: 25144481536     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2005.07.005     Document Type: Article

References (44)

1. R. Ross Atherosclerosis-an inflammatory disease N. Engl. J. Med. 340 1999 115 126
2. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
3. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
4. S.M. Schwartz, G.R. Campbell, and J.H. Campbell Replication of smooth muscle cells in vascular disease Circ. Res. 58 1986 427 444
5. K.E. Bornfeldt, E.W. Raines, L.M. Graves, M.P. Skinner, E.G. Krebs, and R. Ross Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation Ann. N. Y. Acad. Sci. 766 1995 416 430
6. C.H. Heldin, A. Östman, and L. Rönnstrand Signal transduction via platelet-derived growth factor receptors Biochim. Biophys. Acta 1378 1998 79 113
7. H. Sano, T. Sudo, M. Yokode, T. Murayama, H. Kataoka, N. Takakura, S. Nishikawa, S. Nishikawa, and T. Kita Functional blockade of platelet-derived growth factor receptor-β but not of receptor-α prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice Circulation 103 2001 2955 2960
8. J. Waltenberger Modulation of growth factor action. Implications for the treatment of cardiovascular diseases Circulation 96 1997 4083 4094
9. C.E. Wright, H.H. Tallan, and Y.Y. Lin Taurine: biological update Annu. Rev. Biochem. 55 1986 427 453
10. R.J. Huxtable Physiological actions of taurine Physiol. Rev. 72 1992 101 163
11. S. Murakami, Y. Kondo-Ohta, and K. Tomisawa Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet Life Sci. 64 1999 83 91
12. M.A. Petty, J. Kintz, and G.F. DiFrancesco The effects of taurine on atherosclerosis development in cholesterol-fed rabbits Eur. J. Pharmacol. 180 1990 119 127
13. Y. Kondo, Y. Toda, H. Kitajima, H. Oda, T. Nagate, K. Kameo, and S. Murakami Taurine inhibits development of atherosclerotic lesions in apolipoprotein E-deficient mice Clin. Exp. Pharmacol. Physiol. 28 2001 809 815
14. S. Murakami, Y. Kondo, T. Sakurai, H. Kitajima, and T. Nagate Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits Atherosclerosis 163 2002 79 87
15. Y. Yamori, L. Liu, K. Ikeda, A. Miura, S. Mizushima, T. Miki, and Y. Nara Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study Hypertens. Res. 24 2001 453 457
16. K. Imada, Y. Hosokawa, M. Terashima, T. Mitani, Y. Tanigawa, K. Nakano, T. Takenaga, and M. Kurachi Inhibitory mechanism of taurine on the platelet-derived growth factor BB-mediated proliferation in aortic vascular smooth muscle cells Adv. Exp. Med. Biol. 526 2003 5 15
17. J.H. Campbell, G.R. Campbell, and R. Ross The smooth muscle cell in culture Physiol. Rev. 59 1979 1 61
18. M. Kovalenko, L. Rönnstrand, C.H. Heldin, M. Loubtchenkov, A. Gazit, A. Levitzki, and F.D. Böhmer Phosphorylation site-specific inhibition of platelet-derived growth factor β-receptor autophosphorylation by the receptor blocking tyrphostin AG1296 Biochemistry 36 1997 6260 6269
19. P. Chiarugi, P. Cirri, M.L. Taddei, D. Talini, L. Doria, T. Fiaschi, F. Buricchi, E. Giannoni, G. Camici, G. Raugei, and G. Ramponi New perspectives in PDGF receptor downregulation: the main role of phosphotyrosine phosphatases J. Cell Sci. 115 2002 2219 2232
20. M. Terashima, T. Mitani, Y. Hosokawa, Y. Nariai, K. Imada, E. Kageyama, and Y. Tanigawa Suppressive effect of taurine on platelet-derived growth factor BB-induced c-fos and c-jun mRNA expressions through extracellular signal-regulated kinase (ERK) in mesenchymal cell lines J. Nutr. Sci. Vitaminol. 49 2003 187 194
21. K. Imada, T. Takenaga, S. Otomo, Y. Hosokawa, and M. Totani Taurine attenuates the induction of immediate-early gene expression by PDGF-BB Adv. Exp. Med. Biol. 483 2000 589 594
22. E. Porreca, R. Ciccarelli, C.D. Febbo, and F. Cuccurullo Protein kinase C pathway and proliferative responses of aged and young rat vascular smooth muscle cells Atherosclerosis 104 1993 137 145
23. Y. Ueda, S. Hirai, S. Osada, A. Suzuki, K. Mizuno, and S. Ohno Protein kinase Cδ activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf J. Biol. Chem. 271 1996 23512 23519
24. E. Sturani, L.M. Vicentini, R. Zippel, L. Toschi, A. Pandiella-Alonso, P.M. Comoglio, and J. Meldolesi PDGF-induced receptor phosphorylation and phosphoinositide hydrolysis are unaffected by protein kinase C activation in mouse Swiss 3T3 and human skin fibroblasts Biochem. Biophys. Res. Commun. 137 1986 343 350
25. J.B. Lombardini Effects of taurine on calcium ion uptake and protein phosphorylation in rat retinal membrane preparations J. Neurochem. 45 1985 268 275
26. J. Maturo, and E.C. Kulakowski Taurine binding to the purified insulin receptor Biochem. Phamacol. 37 1988 3755 3760
27. F.D. Böhmer, A. Böhmer, A. Obermeier, and A. Ullrich Use of selective tyrosine kinase blockers to monitor growth factor receptor dephosphorylation in intact cells Anal. Biochem. 228 1995 267 273
28. A. Östman, and F.D. Böhmer Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases Trends Cell Biol. 11 2001 258 266
29. S.M. Sanz-González, C. Castro, P. Pérez, and V. Andrés Role of E2F and ERK1/2 in STI571-mediated smooth muscle cell growth arrest and cyclin A transcriptional repression Biochem. Biophys. Res. Commun. 317 2004 972 979
30. M. Myllärniemi, J. Frösen, L.G. Calderón Ramirez, E. Buchdunger, K. Lemström, and P. Häyry Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo Cardiovasc. Drugs Ther. 13 1999 159 168
31. K.E. Lipson, L. Pang, L.J. Huber, H. Chen, J.M. Tsai, P. Hirth, A. Gazit, A. Levitzki, and G. McMahon Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation J. Pharmacol. Exp. Ther. 285 1998 844 852
32. Y.R. Shi, L. Gao, S.H. Wang, D.F. Bu, B.H. Zhang, H.F. Jiang, Y.Z. Pang, and C.S. Tang Inhibition of taurine transport by high concentration of glucose in cultured rat cardiomyocytes Metabolism 52 2003 827 833
33. W. Chen, K. Matuda, N. Nishimura, and H. Yokogoshi The effect of taurine on cholesterol degradation in mice fed a high-cholesterol diet Life Sci. 74 2004 1889 1898
34. Y. Zhan, S. Kim, Y. Izumi, Y. Izumiya, T. Nakao, H. Miyazaki, and H. Iwao Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression Arterioscler. Thromb. Vasc. Biol. 23 2003 795 801
35. G. Gennaro, C. Ménard, E. Giasson, S.É. Michaud, M. Palasis, S. Meloche, and A. Rivard Role of p44/p42 MAP kinase in the age-dependent increase in vascular smooth muscle cell proliferation and neointimal formation Arterioscler. Thromb. Vasc. Biol. 23 2003 204 210
36. r protein tyrosine phosphatase inhibits growth and migration of vascular smooth muscle cells induced by platelet-derived growth factor Biochem. Biophys. Res. Commun. 289 2001 602 607
37. M.B. Wright, R.A. Seifert, and D.F. Bowen-Pope Protein tyrosine phosphatases in the vessel wall: differential expression after acute arterial injury Arterioscler. Thromb. Vasc. Biol. 20 2000 1189 1198
38. V.J. Thannickal, and B.L. Fanburg Reactive oxygen species in cell signaling Am. J. Physiol., Lung Cell. Mol. Physiol. 279 2000 1005 1028
39. 2 and vanadate in vitro Biochem. Biophys. Res. Commun. 188 1992 773 779
40. 2 for platelet-derived growth factor signal transduction Science 270 1995 296 299
41. T.J. Hsieh, S.L. Zhang, J.G. Filep, S.S. Tang, J.R. Ingelfinger, and J.S.D. Chan High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells Endocrinology 143 2002 2975 2985
42. G.Y. Oudit, M.G. Trivieri, N. Khaper, T. Husain, G.J. Wilson, P. Liu, M.J. Sole, and P.H. Backx Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model Circulation 109 2004 1877 1885
43. I.G. Obrosova, L. Fathallah, and M.J. Stevens Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy Exp. Neurol. 172 2001 211 219
44. T. Marumo, V.B. Schini-Kerth, B. Fisslthaler, and R. Busse Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-κB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells Circulation 96 1997 2361 2367